K. Monostory et L. Vereczkey, THE EFFECT OF IPRIFLAVONE AND ITS MAIN METABOLITES ON THEOPHYLLINE BIOTRANSFORMATION, European journal of drug metabolism and pharmacokinetics, 21(1), 1996, pp. 61-66
The effect of ipriflavone and its major metabolites, 7-hydroxy-isoflav
one and 7-(1-carboxy-ethoxy)-isoflavone on theophylline metabolism was
examined in vitro in human liver microsomes. The compounds inhibited
the N-demethylation to 1- or 3-methylxanthine, the major pathway of th
eophylline metabolism. The effect showed concentration dependence. The
oxidation of theophylline to 1,3-dimethyiuric acid was slightly affec
ted by ipriflavone and its metabolites and the effect was non-specific
. Results indicate that the reduction of theophylline clearance by con
comitant ipriflavone administration observed by Takahashi et al. [Taka
hashi J., Kawakatsu K., Wakayama T., Sawaoka H. (1992) : Elevation of
serum theophylline levels by ipriflavone in a patient with chronic obs
tructive pulmonary disease. fur. J. Clin. Pharmacol., 43, 207-208] is
primarily due to an interaction of the inhibitory ipriflavone and/or i
ts metabolites with cytochrome P450 enzyme(s) that mediate N-demethyla
tion of theophylline.